自动注射器市场——按类型、给药途径、疗法、最终用途、全球预测,2023-2032 年
市场调查报告书
商品编码
1267456

自动注射器市场——按类型、给药途径、疗法、最终用途、全球预测,2023-2032 年

Autoinjectors Market - By Type, By Route of Administration, By Therapy,, By End-use & Global Forecast, 2023 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 175 Pages | 商品交期: 2-3个工作天内

价格

全球自动注射器市场预计到 2032 年将呈指数增长,这是由于慢性病的增加导致对靶向治疗的需求不断增长。

此外,新型靶向药物的推出和药物开发投资有望推动自动注射器市场的增长。

此外,对自行服用药物的日益偏爱将推动未来几年的市场需求。 此外,减少大型生物製剂产品组合中使用的设计变更的时间、风险和成本的需求日益增长,预计将推动产品在全球范围内的采用。

全球自动注射器行业的主要参与者继续采取战略举措,例如併购、合作伙伴关係以及引入带有一次性盒和电子驱动器的可重复使用自动注射器。 这些可重复使用的自动注射器包含预填充注射器,在最大限度地使用新药的同时提供针头安全性。 这种新兴市场的发展正在推动更多患者使用自动注射器进行自我治疗,进一步促进市场扩张。

总体而言,全球自动注射器市场在类型、给药途径、治疗、最终用途和区域方面存在分歧。

按类型划分,预计到 2022 年一次性用品的收入份额将超过 370 亿美元,并在 2032 年之前实现显着增长。 这种增长可归因于一次性自动注射器提供的卓越功能,例如以患者为中心和支持完整药物输注的易用性。

按给药途径,肌肉注射器预计会显着增长,因为它们用于过敏反应和过敏反应。 此外,由于它在紧急情况下发挥重要作用,因此有望扩大该领域。

基于治疗,糖尿病细分市场预计将在 2022 年占据超过 23% 的市场份额,并在 2032 年之前呈指数增长。 这种增长是由于糖尿病患者人数的增加和相关费用的增加。 世界卫生组织估计约有 4.22 亿人患有糖尿病。

在最终用途方面,由于自动注射器提供的好处(例如管理过敏反应、糖尿病、急性发作、焦虑等),预计从 2023 年到 2032 年家庭护理环境部分将显着增长。 此外,该产品的易用性、剂量控制和自我管理等特点有望在未来支持细分市场扩张。

按地区划分,预计欧洲自动注射器市场在 2023 年至 2032 年期间的市场份额将超过 20%。 医疗器械行业的兴起、监管框架的变化以及临床试验/证据的透明度是估计刺激欧洲自动注射器行业增长的主要因素。

内容

第 1 章研究方法和范围

第 2 章执行摘要

第 3 章自动注射器行业洞察

  • 按行业细分
  • 影响行业的因素
    • 司机
      • 对靶向药物的需求不断增长
      • 启动自动注射器仿製药的全球销售
      • 糖尿病和过敏反应的发生率增加
      • 增加了患者对药物自我管理的偏好
    • 行业潜在的风险和挑战
      • 存在或不存在替代治疗方案
      • 自动注射器定价高
  • 增长分析
    • 按类型
    • 按给药途径
    • 通过治疗
    • 按最终用途
  • COVID-19 影响分析
  • 监管状况
    • 美国
    • 欧洲
  • 技术概况
  • 工业生态系统
    • 当前行业趋势
    • 启动场景
  • 波特分析
  • PESTEL 分析

第四章竞争格局

  • 简介
  • 每家公司的市场份额(2021 年)
  • 主要市场参与者的竞争分析
  • 竞争对手定位矩阵
  • 战略视角矩阵

第 5 章自动注射器市场:按类型

  • 主要类型趋势
  • 一次性的
  • 可重复使用

第 6 章自动注射器市场:按给药途径

  • 主要给药途径的趋势
  • 皮下
  • 肌肉注射

第 7 章自动注射器市场:按治疗

  • 主要治疗趋势
  • 类风湿性关节炎
  • 多发性硬化症
  • 过敏反应
  • 糖尿病
  • 肿瘤
  • 支气管哮喘
  • 偏头痛
  • 激素疗法
  • 其他

第 8 章自动注射器市场:按最终用途分类

  • 主要的最终用户趋势
  • 医院和诊所
  • 家庭护理设置
  • 其他

第 9 章自动注射器市场:按地区

  • 主要区域趋势
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙特阿拉伯

第十章公司简介

  • AbbVie Inc.
  • Mylan
  • GlaxoSmithKline Plc.
  • Ypsomed
  • Amgen
  • Becton, Dickinson and company
  • Eli Lilly and Company
  • Johnson & Johnson
  • Teva pharmaceuticals
  • Antares Pharma
Product Code: 5412

Global Autoinjectors Market is slated to grow exponentially by 2032, owing to the rising demand for targeted therapies, in light of the growing prevalence of chronic diseases. In addition, introduction to novel targeted medicines and investments in drug development is slated to drive the growth of the autoinjectors market.

Besides, the rising preference for self-administration medication would propel the market demand in the ensuing years. Moreover, the increasing requirement to reduce the time and risk and expense of modifying designs that could be used across large biologic pharmaceutical portfolios are anticipated to foster the product adoption worldwide.

The key players in the global autoinjector industry are continuously incorporating strategic initiatives such as mergers and acquisitions, partnerships, and introducing reusable autoinjectors with disposable cassettes and electronic drive units. These reusable autoinjectors contain prefilled syringes and provide needle safety while maximizing the use of novel drugs. Such developments encourage more patients to use autoinjectors for self-administered medications, further augmenting market expansion.

Overall, the global autoinjectors market is bifurcated in terms of type, route of administration, therapy, end-use, and region.

Considering the type, the disposables segment held over USD 37 billion revenue share in 2022 and is slated to demonstrate massive growth through 2032. The growth can be attributed to the exceptional features offered by disposable autoinjectors, such as being patient-centric and easy operability to support the complete injection of medication.

By route of administration, the intramuscular autoinjectors segment is slated to grow considerably owing to its use for anaphylaxis and allergic reactions. In addition, these autoinjectors play a key role during an emergency, which will further support the segmental expansion.

Based on therapy, the diabetes segment held more than 23% market share in 2022 and is expected to grow exponentially through 2032. The growth can be credited to the rising cases and subsequent increase in expenses of diabetes. As per WHO estimates, approximately 422 million people suffer from diabetes.

By end-use, the homecare settings segment is depicted to grow notably during 2023-2032, owing to the benefits offered by autoinjectors, including managing anaphylaxis, diabetes, acute seizures, anxiety, and others. In addition, the product's capabilities, such as being easy usage, controlled dosage, and self-administrability, are further expected to support the segmental expansion in the future.

Regionally, the Europe global autoinjectors market is slated to exhibit over 20% market share between 2023-2032. The rising medical device industry, changes in the regulatory framework and transparency in the clinical trials/evidence are some key factors that are estimated to stimulate the Europe autoinjector industry growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates and calculations
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 MEA
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 COVID-19 impact analysis at global level
  • 1.7 Data sources
    • 1.7.1 Secondary
      • 1.7.1.1 Paid sources
      • 1.7.1.2 Unpaid sources
    • 1.7.2 Primary

Chapter 2 Executive Summary

  • 2.1 Autoinjectors market industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Type trends
    • 2.1.3 Route of administration trends
    • 2.1.4 Therapy trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Autoinjectors Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing demand for targeted therapies
      • 3.2.1.2 Availability of generic autoinjectors globally
      • 3.2.1.3 Increasing incidence of diabetes and anaphylaxis
      • 3.2.1.4 Rising patient preference towards self-administration of medication
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Availability of alternative treatment options
      • 3.2.2.2 High pricing of the autoinjectors
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By route of administration
    • 3.3.3 By therapy
    • 3.3.4 By end-use
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Technology landscape
  • 3.7 Industry eco-system
    • 3.7.1 Current trends in the industry
    • 3.7.2 Start-up scenario
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive landscape

  • 4.1 Introduction
  • 4.2 Company market share, 2021
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic outlook matrix

Chapter 5 Autoinjectors Market, By Type

  • 5.1 Key type trends
  • 5.2 Disposable
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Reusable
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Autoinjectors Market, By Route of Administration

  • 6.1 Key route of administration trends
  • 6.2 Subcutaneous
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Intramuscular
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Autoinjectors Market, By Therapy

  • 7.1 Key therapy trends
  • 7.2 Rheumatoid arthritis
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Multiple sclerosis
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.4 Anaphylaxis
    • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.5 Diabetes
    • 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.6 Oncology
    • 7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.7 Asthma
    • 7.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.8 Migraine
    • 7.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.9 Hormone therapy
    • 7.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.10 Others
    • 7.10.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Autoinjectors Market, By End-use

  • 8.1 Key end-use trends
  • 8.2 Hospital & clinics
    • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.3 Homecare Settings
    • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.4 Others
    • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Autoinjectors Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia

Chapter 10 Company Profiles

  • 10.1 AbbVie Inc.
  • 10.2 Mylan
  • 10.3 GlaxoSmithKline Plc.
  • 10.4 Ypsomed
  • 10.5 Amgen
  • 10.6 Becton, Dickinson and company
  • 10.7 Eli Lilly and Company
  • 10.8 Johnson & Johnson
  • 10.9 Teva pharmaceuticals
  • 10.10 Antares Pharma

Data Tables

  • TABLE 1. Autoinjectors market, 2018 - 2024 (USD Million)
  • TABLE 2. Autoinjectors market, 2025- 2032(USD Million)
  • TABLE 3. Autoinjectors market, by type, 2018 - 2024 (USD Million)
  • TABLE 4. Autoinjectors market, by type, 2025- 2032 (USD Million)
  • TABLE 5. Autoinjectors market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 6. Autoinjectors market, by route of administration, 2025- 2032(USD Million)
  • TABLE 7. Autoinjectors market, by therapy, 2018 - 2024 (USD Million)
  • TABLE 8. Autoinjectors market, by therapy, 2025- 2032(USD Million)
  • TABLE 9. Autoinjectors market, by end-use, 2018 - 2024 (USD Million)
  • TABLE 10. Autoinjectors market, by end-use, 2025- 2032(USD Million)
  • TABLE 11. Autoinjectors market, by region, 2018 - 2024 (USD Million)
  • TABLE 12. Autoinjectors market, by region, 2025- 2032(USD Million)
  • TABLE 13. Industry impact forces
  • TABLE 14. Disposable market size, by region, 2018 - 2024 (USD Million)
  • TABLE 15. Disposable market, by region, 2025- 2032(USD Million)
  • TABLE 16. Reusable market size, by region, 2018 - 2024 (USD Million)
  • TABLE 17. Reusable market, by region, 2025- 2032(USD Million)
  • TABLE 18. Subcutaneous market size, by region, 2018 - 2024 (USD Million)
  • TABLE 19. Subcutaneous market, by region, 2025- 2032(USD Million)
  • TABLE 20. Intramuscular market size, by region, 2018 - 2024 (USD Million)
  • TABLE 21. Intramuscular market, by region, 2025- 2032(USD Million)
  • TABLE 22. Rheumatoid arthritis market size, by region, 2018 - 2024 (USD Million)
  • TABLE 23. Rheumatoid arthritis market, by region, 2025- 2032(USD Million)
  • TABLE 24. Multiple sclerosis market size, by region, 2018 - 2024 (USD Million)
  • TABLE 25. Multiple sclerosis market, by region, 2025- 2032(USD Million)
  • TABLE 26. Anaphylaxis market size, by region, 2018 - 2024 (USD Million)
  • TABLE 27. Anaphylaxis market, by region, 2025- 2032(USD Million)
  • TABLE 28. Diabetes market size, by region, 2018 - 2024 (USD Million)
  • TABLE 29. Diabetes market, by region, 2025- 2032(USD Million)
  • TABLE 30. Oncology market size, by region, 2018 - 2024 (USD Million)
  • TABLE 31. Oncology market, by region, 2025- 2032(USD Million)
  • TABLE 32. Asthma market size, by region, 2018 - 2024 (USD Million)
  • TABLE 33. Asthma market, by region, 2025- 2032(USD Million)
  • TABLE 34. Migraine market size, by region, 2018 - 2024 (USD Million)
  • TABLE 35. Migraine market, by region, 2025- 2032(USD Million)
  • TABLE 36. Hormone therapy market size, by region, 2018 - 2024 (USD Million)
  • TABLE 37. Hormone therapy market, by region, 2025- 2032(USD Million)
  • TABLE 38. Other cancers market size, by region, 2018 - 2024 (USD Million)
  • TABLE 39. Other cancers market, by region, 2025- 2032 (USD Million)
  • TABLE 40. Hospital & clinics market size, by region, 2018 - 2024 (USD Million)
  • TABLE 41. Hospital & clinics market, by region, 2025- 2032(USD Million)
  • TABLE 42. Homecare settings market size, by region, 2018 - 2024 (USD Million)
  • TABLE 43. Homecare settings market, by region, 2025- 2032(USD Million)
  • TABLE 44. Other cancers market size, by region, 2018 - 2024 (USD Million)
  • TABLE 45. Other cancers market, by region, 2025- 2032(USD Million)
  • TABLE 46. North America autoinjector market size, by country, 2018 - 2024 (USD Million)
  • TABLE 47. North America autoinjector market size, by country, 2025- 2032 (USD Million)
  • TABLE 48. North America autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 49. North America autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 50. North America autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 51. North America autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 52. North America autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 53. North America autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 54. North America autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 55. North America autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 56. U.S. autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 57. U.S. autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 58. U.S. autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 59. U.S. autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 60. U.S. autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 61. U.S. autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 62. U.S. autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 63. U.S. autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 64. Canada autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 65. Canada autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 66. Canada autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 67. Canada autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 68. Canada autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 69. Canada autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 70. Canada autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 71. Canada autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 72. Europe autoinjector market size, by country, 2018 - 2024 (USD Million)
  • TABLE 73. Europe autoinjector market size, by country, 2025- 2032 (USD Million)
  • TABLE 74. Europe autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 75. Europe autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 76. Europe autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 77. Europe autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 78. Europe autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 79. Europe autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 80. Europe autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 81. Europe autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 82. Germany autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 83. Germany autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 84. Germany autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 85. Germany autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 86. Germany autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 87. Germany autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 88. Germany autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 89. Germany autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 90. UK autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 91. UK autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 92. UK autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 93. UK autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 94. UK autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 95. UK autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 96. UK autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 97. UK autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 98. France autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 99. France autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 100. France autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 101. France autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 102. France autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 103. France autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 104. France autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 105. France autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 106. Italy autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 107. Italy autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 108. Italy autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 109. Italy autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 110. Italy autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 111. Italy autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 112. Italy autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 113. Italy autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 114. Spain autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 115. Spain autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 116. Spain autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 117. Spain autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 118. Spain autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 119. Spain autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 120. Spain autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 121. Spain autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 122. Asia Pacific autoinjector market size, by country, 2018 - 2024 (USD Million)
  • TABLE 123. Asia Pacific autoinjector market size, by country, 2025- 2032 (USD Million)
  • TABLE 124. Asia Pacific autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 125. Asia Pacific autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 126. Asia Pacific autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 127. Asia Pacific autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 128. Asia Pacific autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 129. Asia Pacific autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 130. Asia Pacific autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 131. Asia Pacific autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 132. Japan autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 133. Japan autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 134. Japan autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 135. Japan autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 136. Japan autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 137. Japan autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 138. Japan autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 139. Japan autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 140. China autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 141. China autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 142. China autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 143. China autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 144. China autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 145. China autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 146. India autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 147. India autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 148. India autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 149. India autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 150. India autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 151. India autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 152. India autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 153. India autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 154. Australia autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 155. Australia autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 156. Australia autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 157. Australia autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 158. Australia autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 159. Australia autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 160. Australia autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 161. Australia autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 162. Latin America autoinjector market size, by country, 2018 - 2024 (USD Million)
  • TABLE 163. Latin America autoinjector market size, by country, 2025- 2032 (USD Million)
  • TABLE 164. Latin America autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 165. Latin America autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 166. Latin America autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 167. Latin America autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 168. Latin America autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 169. Latin America autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 170. Latin America autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 171. Latin America autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 172. Brazil autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 173. Brazil autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 174. Brazil autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 175. Brazil autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 176. Brazil autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 177. Brazil autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 178. Brazil autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 179. Brazil autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 180. Mexico autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 181. Mexico autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 182. Mexico autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 183. Mexico autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 184. Mexico autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 185. Mexico autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 186. Mexico autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 187. Mexico autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 188. MEA autoinjector market size, by country, 2018 - 2024 (USD Million)
  • TABLE 189. MEA autoinjector market size, by country, 2025- 2032 (USD Million)
  • TABLE 190. MEA autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 191. MEA autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 192. MEA autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 193. MEA autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 194. MEA autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 195. MEA autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 196. MEA autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 197. MEA autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 198. South Africa autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 199. South Africa autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 200. South Africa autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 201. South Africa autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 202. South Africa autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 203. South Africa autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 204. South Africa autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 205. South Africa autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 206. Saudi Arabia autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 207. Saudi Arabia autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 208. Saudi Arabia autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 209. Saudi Arabia autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 210. Saudi Arabia autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 211. Saudi Arabia autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 212. Saudi Arabia autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 213. Saudi Arabia autoinjector market size, by end-use, 2025- 2032 (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Industry segmentation
  • FIG. 3 Top-down approach
  • FIG. 4 Market estimation and forecast methodology
  • FIG. 5 Market forecasting methodology
  • FIG. 6 Breakdown of primary participants
  • FIG. 7 Autoinjectors industry 360 degree synopsis, 2018 - 2032
  • FIG. 8 Industry segmentation
  • FIG. 9 Global autoinjectors market, 2018 - 2032 (USD Million)
  • FIG. 10 Growth potential analysis, by type
  • FIG. 11 Growth potential analysis, by route of administration
  • FIG. 12 Growth potential analysis, by therapy
  • FIG. 13 Growth potential analysis, by end-use
  • FIG. 14 Porter's analysis
  • FIG. 15 PESTEL analysis
  • FIG. 16 Competitive dashboard, 2021
  • FIG. 17 Company matrix analysis, 2021
  • FIG. 18 Competitive analysis of major market players, 2021
  • FIG. 19 Competitive positioning matrix
  • FIG. 20 Strategic outlook matrix